Global Erectile Dysfunction Market : Detailed Eli Lilly, Pfizer, Bayer, Boston Scientific and more Key Venders.



The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.

Press Release

This report studies the global Erectile Dysfunction market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Erectile Dysfunction market by companies, region, type and end-use industry.

Request For Sample @

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.
The ED drugs segment led the market and accounted for almost 80% of the market share in terms of revenue.
In terms of geography, the Americas dominated the global erectile dysfunction market and is expected to hold close to 50% of the market share.
In 2017, the global Erectile Dysfunction market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global top players, covered
Eli Lilly
Boston Scientific
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
SK Chemical
Teva Pharmaceuticals
Zephyr Surgical Implants (ZSI)

Market segment by Regions/Countries, this report covers
United States
Southeast Asia

Market segment by Type, the product can be split into
ED Drugs
ED Devices

Request For Discount @

Market segment by Application, split into
Congenital Patients
Pathological Patients

The study objectives of this report are:
To study and forecast the market size of Erectile Dysfunction in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Erectile Dysfunction Market Size, Status and Forecast 2025
1 Industry Overview of Erectile Dysfunction
1.1 Erectile Dysfunction Market Overview
1.1.1 Erectile Dysfunction Product Scope
1.1.2 Market Status and Outlook
1.2 Global Erectile Dysfunction Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Erectile Dysfunction Market by Type
1.3.1 ED Drugs
1.3.2 ED Devices
1.4 Erectile Dysfunction Market by End Users/Application
1.4.1 Congenital Patients
1.4.2 Pathological Patients

2 Global Erectile Dysfunction Competition Analysis by Players
2.1 Erectile Dysfunction Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

Browse Complete Report @

3 Company (Top Players) Profiles
3.1 Eli Lilly
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.2 Pfizer
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.3 Bayer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.4 Boston Scientific
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.5 Coloplast
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.6 Apricus Biosciences
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.7 Cristalia Produtos Quimicos Farmaceuticos
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.8 Dong-A Socio
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.9 Endo Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.10 Futura Medical
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Erectile Dysfunction Revenue (Million USD) (2013-2018)
3.11 Meda Pharmaceuticals
3.12 Promedon
3.13 SK Chemical
3.14 Teva Pharmaceuticals
3.15 Vivus
3.16 Zephyr Surgical Implants (ZSI)

4 Global Erectile Dysfunction Market Size by Type and Application (2013-2018)
4.1 Global Erectile Dysfunction Market Size by Type (2013-2018)
4.2 Global Erectile Dysfunction Market Size by Application (2013-2018)
4.3 Potential Application of Erectile Dysfunction in Future
4.4 Top Consumer/End Users of Erectile Dysfunction